AI assistant
Snap-on Inc — Director's Dealing 2023
Jun 14, 2023
30335_dirs_2023-06-14_1cb617cd-e6f3-42de-b603-b3c9df592b6c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Snap-on Inc (SNA)
CIK: 0000091440
Period of Report: 2023-06-13
Reporting Person: Pagliari Aldo John (Sr VP - Finance & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-06-13 | Common Stock | M | 6000 | $109.43 | Acquired | 88822.1633 | Direct |
| 2023-06-13 | Common Stock | S | 100 | $266.93 | Disposed | 88722.1633 | Direct |
| 2023-06-13 | Common Stock | S | 200 | $268.85 | Disposed | 88522.1633 | Direct |
| 2023-06-13 | Common Stock | S | 473 | $270.1779 | Disposed | 88049.1633 | Direct |
| 2023-06-13 | Common Stock | S | 1945 | $271.2571 | Disposed | 86104.1633 | Direct |
| 2023-06-13 | Common Stock | S | 1390 | $271.8359 | Disposed | 84714.1633 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-06-13 | Stock Option (Right to Buy) | $109.43 | M | 6000 | Disposed | 2024-02-13 | Common Stock (6000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $144.69 | 2025-02-12 | Common Stock (34000) | 34000 | Direct |
| Stock Option (Right to Buy) | $138.03 | 2026-02-11 | Common Stock (35000) | 35000 | Direct |
| Stock Option (Right to Buy) | $168.70 | 2027-02-09 | Common Stock (36000) | 36000 | Direct |
| Stock Option (Right to Buy) | $161.18 | 2028-02-15 | Common Stock (26052) | 26052 | Direct |
| Stock Option (Right to Buy) | $155.92 | 2029-02-14 | Common Stock (23500) | 23500 | Direct |
| Stock Option (Right to Buy) | $155.34 | 2030-02-13 | Common Stock (23500) | 23500 | Direct |
| Stock Option (Right to Buy) | $189.89 | 2031-02-11 | Common Stock (14986) | 14986 | Direct |
| Stock Option (Right to Buy) | $211.67 | 2032-02-10 | Common Stock (11252) | 11252 | Direct |
| Stock Option (Right to Buy) | $249.26 | 2033-02-09 | Common Stock (7850) | 7850 | Direct |
| Restricted Stock Units | $ | 2024-02-11 | Common Stock (2337) | 2337 | Direct |
| Restricted Stock Units | $ | 2025-02-10 | Common Stock (1924) | 1924 | Direct |
| Restricted Stock Units | $ | 2026-02-09 | Common Stock (1793) | 1793 | Direct |
| Performance Units | $ | Common Stock (4673) | 4673 | Direct | |
| Performance Units | $ | Common Stock (3847) | 3847 | Direct | |
| Performance Units | $ | Common Stock (3586) | 3586 | Direct |
Footnotes
F1: The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on December 7, 2022.
F2: Includes 31.8724 shares acquired under a dividend reinvestment plan.
F3: This transaction was executed in multiple trades at prices ranging from $268.41 to $269.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
F4: This transaction was executed in multiple trades at prices ranging from $269.59 to $270.56. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
F5: This transaction was executed in multiple trades at prices ranging from $270.62 to $271.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
F6: This transaction was executed in multiple trades at prices ranging from $271.62 to $272.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
F7: Option fully vested.
F8: Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on December 7, 2022.
F9: Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column.
F10: 1 for 1.
F11: The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment.
F12: If the Company achieves certain goals over the 2021-2023 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
F13: If the Company achieves certain goals over the 2022-2024 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
F14: If the Company achieves certain goals over the 2023-2025 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.